Statistics
Publications
2
Citations
955
H-Index
2
Active since
2003
Affiliations
Maxygen (United States)(Current)
Lily Wong is an author at Maxygen (United States) specializing in pharmacology, oncology, and molecular oncology.
Publications per year
2003–2003
2
2
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11
1–2 of 2